Photo: GSK's corporate headquarters in Brentford, London / Courtesy of GSK
28 February 2014Americas
Federal Circuit rejects challenge to GSK’s Avodart and Jalyn
The US Appeals Court for the Federal Circuit has affirmed a lower court decision that GlaxoSmithKline’s (GSK’s) patent covering Avodart and Jalyn is valid, rejecting claims put forward by a group of generic drug makers.
